Clinical research of etomidate in obese people undergoing sedated endoscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003162

Enrollment

Unknown

Registered

2013-03-05

Start date

2013-03-30

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases of upper digestive tract

Interventions

Group A:Anesthesia with etomidate

Group B:Anesthesia with propofol

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years old; 2. BMI>=25kg/m2; 3. American Society of Anesthesiologists (ASA) classified I-III level; 4. Ability to respond to a self-administered questionnaire, and being nave to sedated endoscopy.

Exclusion criteria

Exclusion criteria: 1. serious cardiopulmonary compromise,hepatic or renal dysfunction, or metabolic diseases and electrolyte imbalance; 2. BP>180/110mmHg; 3. respiratory acute inflammation in nearly two weeks; 4. allergy or addiction to emulsion or opioid; 5. Degree II atrioventricular block or complete left bundle branch block showed in ECG.

Design outcomes

Primary

Measure	Time frame
the hemodynamic changes;adverse reaction;	—

Secondary

Measure	Time frame
recovery time;diagnostic accuracy;patient and doctor's satisfaction;	—

Countries

China

Contacts

Public ContactChunhui LAN

tiandaochouqin99@hotmail.com+86 13896067955

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026